Valuation: DiaSorin S.p.A.

Market Cap 404.71Cr 451.08Cr 374.17Cr 338.87Cr 633.1Cr 43TCr 640.75Cr 4.47TCr 1.78TCr 22TCr 1.69TCr 1.66TCr 71TCr P/E 2026 *
24.5x
P/E 2027 * 20.9x
Enterprise Value 474.14Cr 528.46Cr 438.36Cr 397.01Cr 741.71Cr 50TCr 750.68Cr 5.24TCr 2.09TCr 26TCr 1.98TCr 1.94TCr 84TCr EV / Sales 2026 *
3.83x
EV / Sales 2027 * 3.5x
Free-Float
37.17%
Yield 2026 *
1.61%
Yield 2027 * 1.68%
1 day+1.31%
1 week+4.61%
Current month+6.46%
1 month+3.13%
3 months+15.77%
6 months+41.11%
Current year+19.15%
1 week 78.16
Extreme 78.16
81.98
1 month 72.8
Extreme 72.8
82.3
Current year 52.34
Extreme 52.34
82.3
1 year 52.34
Extreme 52.34
82.3
3 years 52.34
Extreme 52.34
112.35
5 years 52.34
Extreme 52.34
204.4
10 years 49.98
Extreme 49.98
211.8
Manager TitleAgeSince
Chief Executive Officer 60 26/03/2007
Director of Finance/CFO - 01/01/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 28/04/2016
Director/Board Member 63 26/03/2007
Chairman 57 29/04/2022
Date Insider Type Main position Quantity % Market Cap. Importance
24/03/26 Buy

Chief Executive Officer

9,211 0.0165%
28/01/26 Buy

Chief Executive Officer

7,500 0.0134%
08/01/26 Buy

Director

700 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
+1.31%+4.61%+5.85%-0.39% 445.08Cr
-0.45%+2.12%-18.93%+10.37% 18TCr
+0.86%+2.15%-19.13%+15.77% 12TCr
+0.88%+1.88%+1.66%+35.46% 12TCr
-2.26%+18.07%-43.85%+5.76% 9.31TCr
-0.31%-4.72%-3.36%+74.94% 6.21TCr
+0.17%+1.64%+8.50%+82.24% 5.59TCr
+0.07%+0.42%+5.94%-22.27% 5.31TCr
+0.30%+1.70%-11.26%+42.01% 4.42TCr
+0.10%+3.08%-3.06%-8.74% 3.36TCr
Average +0.22%+2.20%-7.76%+23.51% 7.55TCr
Weighted average by Cap. +0.22%+2.37%-12.54%+23.71%

Financials

2026 *2027 *
Net sales 123.66Cr 137.83Cr 114.33Cr 103.54Cr 193.45Cr 13TCr 195.79Cr 1.37TCr 544.47Cr 6.87TCr 517.22Cr 506.31Cr 22TCr 131.65Cr 146.74Cr 121.72Cr 110.24Cr 205.95Cr 14TCr 208.44Cr 1.46TCr 579.65Cr 7.31TCr 550.64Cr 539.02Cr 23TCr
Net income 18Cr 20Cr 17Cr 15Cr 28Cr 1.92TCr 29Cr 200.21Cr 80Cr 1.01TCr 76Cr 74Cr 3.19TCr 20Cr 23Cr 19Cr 17Cr 32Cr 2.17TCr 32Cr 226.12Cr 90Cr 1.14TCr 86Cr 84Cr 3.61TCr
Net Debt 69Cr 77Cr 64Cr 58Cr 108.62Cr 7.37TCr 109.93Cr 767.51Cr 305.7Cr 3.86TCr 290.4Cr 284.27Cr 12TCr 56Cr 62Cr 51Cr 47Cr 87Cr 5.9TCr 88Cr 614.08Cr 244.59Cr 3.09TCr 232.35Cr 227.45Cr 9.8TCr
Projected Income Statement - Annual - DiaSorin S.p.A.
Logo DiaSorin S.p.A.
DiaSorin SpA is an Italy-based company engaged in healthcare industry. The Company specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. The Company develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The Company’s business activities are divided into two markets. The Immunodiagnostics market develops, produces and markets immunoreagent kits, which are based on three techniques: Chemiluminescence (CLIA), Colorimetry (ELISA) and Radioimmunometry (RIA). The Molecular Diagnostics market supplies end laboratories with an automated result to perform the three steps for the final diagnostic result, including nucleic acids extraction, amplification and diagnosis. It operates through ELISA immunodiagnostic business portfolio.
Employees
3,260
Date Price Change Volume
28/26/28 €81.76 +1.31% 1,19,964
27/26/27 €80.70 -0.25% 1,12,380
26/26/26 €80.90 +1.48% 95,328
23/26/23 €79.72 +0.10% 1,65,324
22/26/22 €79.64 +1.89% 1,51,184
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - DiaSorin S.p.A.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
80.70EUR
Average target price
76.38EUR
Spread / Average Target
-5.35%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - DiaSorin S.p.A.